Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Hereditary Cancer in Clinical Practice|September 3, 2024
Adrenal tumours in patients with pathogenic APC mutations: a retrospective studyLyman Lin, Victoria Beshay, Finlay MacraeJournal of Kidney Cancer and VHL|March 7, 2025
Novel Case of Bilateral Adrenal Tumors Confirms Pathogenicity of Previously Described c.463+4C>G Variant in the von-Hippel Lindau GeneSamuel Morriss, Victoria Beshay, Huei San Leong, et al.BMC Cancer|October 12, 2004
Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: case reportBrett Hughes, Desmond Yip, David Goldstein, et al.Pediatric Blood & Cancer|December 21, 2012
Anaplastic oligodendroglioma in an adolescent with Lynch syndromeJohn A Heath, Jessica Ng, Victoria Beshay, et al.Genes|February 17, 2015
Applicability of next generation sequencing technology in microsatellite instability testingChun Gan, Clare Love, Victoria Beshay, et al.BMC Cancer|June 28, 2011
A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2 genesHeather L Hondow, Stephen B Fox, Gillian Mitchell, et al.Journal of Gynecologic Oncology|October 28, 2021
Insights into ovarian cancer care: report from the ANZGOG Ovarian Cancer Webinar Series 2020Andreas Obermair, Philip Beale, Clare L Scott, et al.Familial Cancer|May 9, 2018
Report of a bi-allelic truncating germline mutation in TP53Natasha J Brown, Kanika Bhatia, Julie Teague, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Suspected clonal hematopoiesis as a natural functional assay of TP53 germline variant pathogenicityCristina Fortuno, Kelly McGoldrick, Tina Pesaran, et al.Haematologica|July 21, 2007
Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, cytokines,angiogenic markers, mast cells and marrow CD57+ cytotoxic T cells as predictors of outcomeLinda Mileshkin, Dirk Honemann, Peter Gambell, et al.Pageof 3